Cancer Donation Dispute Ends in $36.8M Payout

San Diego donors and patients see how a disputed $10 million cancer gift was handled after a whistleblower case.

Updated on Nov. 4, 2026 in Cancer

Bold flat-color editorial illustration of a plain academic building facade in navy and cream with a muted red accent, evoking a quiet institutional reckoning.
UC San Diego agreed to pay former oncologist Kevin Murphy about $36.8 million, including accrued interest, to resolve a whistleblower retaliation case tied to a disputed $10 million cancer donation. AI Illustration. Upload story photo >

UC San Diego has resolved a whistleblower retaliation lawsuit brought by former oncologist Kevin Murphy, who was paid about $36.8 million including interest accrued during the appeal. The resolution follows a 2023 jury award and a 2026 appeals ruling that upheld the verdict while ordering a reduction in damages.

Why it matters

The case centers on a $10 million posthumous donation from a cancer patient that the university intended for Moores Cancer Center, which officials later redirected toward Murphy's brain stimulation research. The outcome closes a dispute over how donated cancer-research funds were handled inside a San Diego academic medical center.

The figures come from a court record: an eight-week San Diego Superior Court trial in 2023, followed by a September 2026 appellate ruling from the 4th District Court of Appeals. The appeal upheld liability but found the $20 million noneconomic award excessive, leaving the final payout as a negotiated figure.

The players

UC San Diego

The University of California campus in San Diego, home to Moores Cancer Center and a major academic medical research enterprise.

Moores Cancer Center

The comprehensive cancer center at UC San Diego, which was the intended recipient of the Kreutzkamp donation.

Kevin Murphy

A former UC San Diego oncologist whose brain stimulation research was at the center of the donation dispute.

The details

Murphy alleged he was retaliated against after raising concerns, and the jury sided with him at trial. The dispute began with a $10 million posthumous gift from cancer patient Charles Kreutzkamp, which the university planned to direct to Moores Cancer Center. Officials eventually funneled the money toward Murphy's brain stimulation research, which Murphy said matched the donor's wishes. The university argued that Murphy violated policies, used donated funds to set up an off-campus research clinic, and enriched himself and his companies.

Timeline

  1. 2023: Jury awarded Murphy $39.5 million after an eight-week trial.

  2. September 10, 2026: Appeals court upheld the verdict but ordered a $12 million reduction.

  3. November 3, 2026: A spokesperson announced the parties had reached a resolution.

Health Landscape

Cases like this one test how whistleblower protections apply inside academic medical centers that depend on philanthropic gifts for cancer research. The dispute highlights the tension between donor-directed funds and institutional research priorities that shapes how cancer centers raise and allocate money.

For patients and families considering donations to cancer research, the case is a reminder to ask how gifts earmarked for a specific center or program are tracked and used. If you are weighing a cancer screening or treatment decision, that conversation belongs with your physician rather than with news coverage.

The takeaway

Donor-directed cancer funds carry accountability questions that patients and families can reasonably raise with institutions. When considering a gift or a research-related decision, ask how the money will be used and whether the program is aligned with the donor's stated wishes.

Further reading

Explore more on Cancer coverage from San Diego for context on how local cancer research and funding stories are unfolding.

Source note: This article includes information reported by San Diego Union-Tribune.